312 related articles for article (PubMed ID: 32678966)
1. The renin-angiotensin system in cutaneous hypertrophic scar and keloid formation.
Hedayatyanfard K; Haddadi NS; Ziai SA; Karim H; Niazi F; Steckelings UM; Habibi B; Modarressi A; Dehpour AR
Exp Dermatol; 2020 Sep; 29(9):902-909. PubMed ID: 32678966
[TBL] [Abstract][Full Text] [Related]
2. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
3. Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid--two case reports and literature review.
Iannello S; Milazzo P; Bordonaro F; Belfiore F
MedGenMed; 2006 Dec; 8(4):60. PubMed ID: 17415337
[TBL] [Abstract][Full Text] [Related]
4. Potential use of angiotensin receptor blockers in skin pathologies.
Hedayatyanfard K; Khalili A; Karim H; Nooraei S; Khosravi E; Haddadi NS; Dehpour AR; Bayat G
Iran J Basic Med Sci; 2023; 26(7):732-737. PubMed ID: 37396936
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
6. Detection of Angiotensin II and AT
Niazi F; Hooshyar SH; Hedayatyanfard K; Ziai SA; Doroodgar F; Niazi S; Habibi B; Asadirad A
J Clin Aesthet Dermatol; 2018 Oct; 11(10):36-39. PubMed ID: 30519378
[No Abstract] [Full Text] [Related]
7. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
Lee HJ; Jang YJ
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of keloid and hypertrophic scar formation.
Tuan TL; Nichter LS
Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
[TBL] [Abstract][Full Text] [Related]
9. Role of chymase in the local renin-angiotensin system in keloids: inhibition of chymase may be an effective therapeutic approach to treat keloids.
Wang R; Chen J; Zhang Z; Cen Y
Drug Des Devel Ther; 2015; 9():4979-88. PubMed ID: 26357464
[TBL] [Abstract][Full Text] [Related]
10. Losartan ointment relieves hypertrophic scars and keloid: A pilot study.
Hedayatyanfard K; Ziai SA; Niazi F; Habibi I; Habibi B; Moravvej H
Wound Repair Regen; 2018 Jul; 26(4):340-343. PubMed ID: 30099811
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
12. The role of the renin-angiotensin system in skin physiology and pathophysiology.
Silva IMS; Assersen KB; Willadsen NN; Jepsen J; Artuc M; Steckelings UM
Exp Dermatol; 2020 Sep; 29(9):891-901. PubMed ID: 32697884
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
14. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
[TBL] [Abstract][Full Text] [Related]
16. [Hyperplastic scars and keloids. Part I: basics and prevention].
Baisch A; Riedel F
HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
[TBL] [Abstract][Full Text] [Related]
17. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.
Liu HW; Cheng B; Yu WL; Sun RX; Zeng D; Wang J; Liao YX; Fu XB
Life Sci; 2006 Jun; 79(5):475-83. PubMed ID: 16522324
[TBL] [Abstract][Full Text] [Related]
19. The link between hypertension and pathological scarring: does hypertension cause or promote keloid and hypertrophic scar pathogenesis?
Huang C; Ogawa R
Wound Repair Regen; 2014; 22(4):462-6. PubMed ID: 24899409
[TBL] [Abstract][Full Text] [Related]
20. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
